Liver Cancer Risk

    Last Updated: October 13, 2024

    Liver cancer is a type of cancer that originates from cells in the liver. "Recurrence of Liver Cancer" refers to the return of liver cancer after remission.

    51,766 participants in 4 trials

    Examine Database: Liver Cancer Risk

    Research FeedRead all studies

    Examine Database References

    1. Vitamin K - Ishizuka M, Kubota K, Shimoda M, Kita J, Kato M, Park KH, Shiraki TEffect of menatetrenone, a vitamin k2 analog, on recurrence of hepatocellular carcinoma after surgical resection: a prospective randomized controlled trialAnticancer Res.(2012 Dec)
    2. Vitamin K - Toshihiko Mizuta, Iwata Ozaki, Yuichiro Eguchi, Tsutomu Yasutake, Seiji Kawazoe, Kazuma Fujimoto, Kyosuke YamamotoThe effect of menatetrenone, a vitamin K2 analog, on disease recurrence and survival in patients with hepatocellular carcinoma after curative treatment: a pilot studyCancer.(2006 Feb 15)
    3. Folic Acid (Vitamin B9) - Vollset SE, Clarke R, Lewington S, Ebbing M, Halsey J, Lonn E, Armitage J, Manson JE, Hankey GJ, Spence JD, Galan P, Bønaa KH, Jamison R, Gaziano JM, Guarino P, Baron JA, Logan RF, Giovannucci EL, den Heijer M, Ueland PM, Bennett D, Collins R, Peto R, B-Vitamin Treatment Trialists' CollaborationEffects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individualsLancet.(2013 Mar 23)
    4. Vitamin K - Dariimaa Ganbat, Bat-Erdene Jugder, Lkhamaa Ganbat, Miki Tomoeda, Erdenetsogt Dungubat, Yoshihisa Takahashi, Ichiro Mori, Takayuki Shiomi, Yasuhiko TomitaThe Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-AnalysisCurr Cancer Drug Targets.(2021)